Maryam Al Khatry, MD
SAN DIEGO—The recently developed minimally invasive anti-obesity procedure, primary obesity surgery endoluminal 2.0, can reverse nonalcoholic fatty liver disease, according to a controlled trial.
“There were improvements in multiple metabolic parameters, and steatosis resolved in most patients” during the study, according to Maryam Al Khatry, MD, the head of the GI Endoscopy Department at Ibrahim Bin Hamad Obaidullah Hospital, in United Arab Emirates, who